Frequently Asked Questions:
It is anticipated that the COVID-19 outbreak will positively affect the organ-on-chip market. A large number of clinics and hospitals around the world were reorganized to increase hospital capacity for COVID-19 patients.
North America projected for the most heightened share in the global Organ-on-chip market.
The demand for organs on a chip is anticipated to increase due to advancements in medical technology and the rising organ transplantation rate.
The lung segment had a major share in the global market in 2022.
The Drug Discovery segment had a major share in the global market.